ResoluteAI unveils new tools to streamline post market surveillance and pharmacovigilance research Six FDA databases now tagged, connected, and searchable on ResoluteAI News provided by Share this article Share this article NEW YORK, April 8, 2021 /PRNewswire/ -- ResoluteAI, the research platform for science, today released a set of tools to streamline post market surveillance and pharmacovigilance analysis. Using data available from OpenFDA, ResoluteAI has connected and enhanced access to six FDA databases: FDA Adverse Event Reporting System (FAERS) Manufacturer and User Facility Device E...